Physician

Adam Tristan Chin, M.D.

According to 2025 Medicare claims, Adam Chin, M.D. (NPI: 1992192884) practices ophthalmology in the Cambridge-Newton-Framingham, MA market, with the plurality of this provider's patient population coming from Middlesex, MA. This provider's primary affiliated billing organization is OPHTHALMIC CONSULTANTS OF BOSTON, INC. (NPI: 1932146594; TIN: 04-2500346) and primary practice location at 01852-1334. Chin is affiliated with the Mass General Brigham ACO, LLC (ACO ID: A4641) and Wellforce ACO, LLC (ACO ID: A4922), participating under the MSSP model.

Chin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,587 traditional Medicare patients, billed 34,732 HCPCS/CPT codes, and received $4,019,536 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 379 prescription claims across 117 beneficiaries totaling $57,372 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 20 records totaling $519. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $9,079 to $4,019,536. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $333 and ending at $57,372. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	60	94	$9,079
2020	117	160	$25,265
2021	1,379	6,451	$1,477,967
2022	1,451	12,850	$2,779,120
2023	1,797	22,931	$3,451,916
2024	1,587	34,732	$4,019,536

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	23	$333
2016	46	91	$9,444
2017	175	547	$118,487
2018	129	280	$64,649
2019	93	223	$37,376
2020	128	328	$38,765
2021	159	377	$39,457
2022	118	355	$53,045
2023	115	484	$71,020
2024	117	379	$57,372

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J0178	Injection, aflibercept, 1 mg	369	3,512	$655
67028	Injection of drug into eye	475	2,091	$102
92014	Established patient complete exam of visual system	1,328	1,664	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	153	196	$65
92134	Imaging of retina	1,523	3,557	$32

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Bromfenac Sodium	Bromfenac Sodium	89	2,551	$19,390
Prolensa	Bromfenac Sodium	21	938	$14,980
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	15	655	$3,483
Prednisolone Acetate	Prednisolone Acetate	45	2,082	$2,154
Difluprednate	Difluprednate	19	589	$913

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	20	$519	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Tristan Chin, M.D.?

Tedicare shows public-source Medicare data for Adam Tristan Chin, M.D. (NPI 1992192884), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Tristan Chin, M.D. have ACO affiliation data?

Adam Tristan Chin, M.D. is shown with ACO affiliation data for Mass General Brigham ACO, LLC (MSSP, ACO ID A4641) and Wellforce ACO, LLC (MSSP, ACO ID A4922).

What billing organization is linked to Adam Tristan Chin, M.D.?

Adam Tristan Chin, M.D. is linked to OPHTHALMIC CONSULTANTS OF BOSTON, INC. (billing NPI 1932146594) in the available physician profile data.

Does Adam Tristan Chin, M.D. have Open Payments data?

Adam Tristan Chin, M.D. has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.